Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Parkinson’s Disease Risk and Hyperhomocysteinemia: The Possible Link
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Yaser Hosny Ali Elewa, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 6, pp. 2743-2759
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali K. Albuhadily, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102233-102233
Closed Access | Times Cited: 16
New insight on the possible role of statins in Vascular Parkinsonism: A need for presumptive therapy
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102209-102209
Closed Access | Times Cited: 14
BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 10
Open Access | Times Cited: 14
Role of GABA pathway in motor and non-motor symptoms in Parkinson's disease: a bidirectional circuit
Bandar Alharbi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 13
The classical and non-classical axes of renin-angiotensin system in Parkinson disease: The bright and dark side of the moon
Hayder M. Al‐kuraishy, Sadiq M. Al‐Hamash, Majid S. Jabir, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102200-102200
Closed Access | Times Cited: 10
The conceivable role of prolactin hormone in Parkinson disease: The same goal but with different ways
Haydar M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102075-102075
Closed Access | Times Cited: 21
Role of brain renin–angiotensin system in depression: A new perspective
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 4
Open Access | Times Cited: 16
Role of uric acid in neurodegenerative diseases, focusing on Alzheimer and Parkinson disease: A new perspective
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Neuropsychopharmacology Reports (2024) Vol. 44, Iss. 3, pp. 639-649
Open Access | Times Cited: 7
Parkinson's disease and vitamins: a focus on vitamin B12
Arwa Rekik, Carlo Santoro, Karolina Popławska-Domaszewicz, et al.
Journal of Neural Transmission (2024)
Open Access | Times Cited: 6
Influence Diet on Cognitive Function and Brain Health
Yuyu Chen, Changhui Zhou
Journal of Biomedical and Sustainable Healthcare Applications (2024), pp. 10-21
Open Access | Times Cited: 5
Peripheral blood immune cells from individuals with Parkinson's disease or inflammatory bowel disease share deficits in iron storage and transport that are modulated by non-steroidal anti-inflammatory drugs
MacKenzie L. Bolen, Beatriz Maffini Gomes, Blake Gill, et al.
Neurobiology of Disease (2025), pp. 106794-106794
Open Access
Dysregulation of serotonergic neurotransmission in Parkinson disease: A key duet
Manal M. Khowdiary, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European Journal of Pharmacology (2025), pp. 177419-177419
Open Access
Decrypting the Possible Mechanistic Role of Fenofibrate in Alzheimer's Disease and Type 2 Diabetes: The Truth and Mystery
Mansour Alsaleem, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 5
Open Access
Combining vinpocetine or cocoa with levodopa, Coenzyme Q10 and vitamin B complex mitigates rotenone-induced Parkinson’s disease in rats: Impact on Nrf2/HO-1, NF-kB, AMPK/SIRT-1/Beclin-1, AKT/GSK-3β/CREB/BDNF and Apoptotic Pathways
Karema Abu-Elfotuh, Mohammed D. Al-Rekabi, Ashwaq N. Abbas, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118011-118011
Closed Access
Neuroprotective Effect Of Thymus Vulgaris On Paraquat Induced Parkinson’s Disease
Naheed Akhter, Iqra Rafiq, Amer Jamil, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151740-151740
Closed Access
Chenodeoxycholic Acid-Mediated neuroprotection via α-synuclein and BDNF Modulation in MPTP-Induced mouse model of Parkinson’s disease
Mehwish Mehreen, Megat Syahirul Amin Megat Ali, Hina Tariq, et al.
Neuroscience (2025)
Closed Access
Irisin/PGC-1α/FNDC5 pathway in Parkinson’s disease: truth under the throes
Naif H. Ali, Nourah Alhamdan, Hayder M. Al‐kuraishy, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 4, pp. 1985-1995
Closed Access | Times Cited: 11
ECHS1-NOX4 interaction suppresses rotenone-induced dopaminergic neurotoxicity through inhibition of mitochondrial ROS production
Zirui Zhao, Ruonan Wang, Haitao Ge, et al.
Free Radical Biology and Medicine (2025)
Closed Access
Bioinorganic Chemistry of Micronutrients Related to Alzheimer’s and Parkinson’s Diseases
Arian Kola, Federico Nencioni, Daniela Valensin
Molecules (2023) Vol. 28, Iss. 14, pp. 5467-5467
Open Access | Times Cited: 9
Folic Acid Rescues Dopaminergic Neurons in MPTP-Induced Mice by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment
Yina Jia, Jing Li, Yutong Wang, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 11, pp. 5734-5745
Closed Access | Times Cited: 3
Association of Increased Homocysteine Levels with Impaired Folate Metabolism and Vitamin B Deficiency in Early-Onset Multiple Sclerosis
Victoria Lioudyno, Evgenia A. Tsymbalova, Ekaterina А. Chernyavskaya, et al.
Biochemistry (Moscow) (2024) Vol. 89, Iss. 3, pp. 562-573
Closed Access | Times Cited: 3
Cyclin‐dependent kinase 5 (CDK5) inhibitors in Parkinson disease
Mohammed Alrouji, Haydar M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 11
Open Access | Times Cited: 3
Dopaminergic system and neurons: role in multiple neurological diseases
Heng Chen, Jieshu Li, Zhixing Huang, et al.
Neuropharmacology (2024) Vol. 260, pp. 110133-110133
Closed Access | Times Cited: 3
The possible role of nuclear factor erythroid‐2‐related factor 2 activators in the management of Covid‐19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Omayma A. Eldahshan, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 8
The neuroprotective effect of vitamin D in Parkinson's disease: association or causation
Amin A. Hafiz
Nutritional Neuroscience (2023) Vol. 27, Iss. 8, pp. 870-886
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top